The discovery of CSMD1's role in epilepsy represents a crucial step forward in unravelling the genetic mysteries of epilepsy.

Research reveals childhood kidney cancer's complex genetic landscape, paving the way for innovative treatments. ...

Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis (SM), a rare immunological disease, and other ...

A new study reveals that music can positively influence infants’ mood, helping soothe and uplift their emotional state.

Men with two copies of the H63D gene variant face over double the risk of dementia, highlighting the need for gender-specific ...

Biomarkers reveal vital insights that could improve treatment strategies for aggressive prostate cancer, offering hope for ...

ASCO 2025 highlights a troubling trend: alcohol-related cancer deaths are increasing across the U.S., raising urgent public ...

FSSAI warns food businesses against using misleading ‘100%’ claims on labels and promotions, urging compliance to ensure ...

TDB supports S3V Vascular in developing India’s first indigenous stroke treatment device, boosting affordable care and ...

InxMed Co., Ltd, a clinical-stage biotechnological company, pioneering therapies to transform cancer treatment, released latest clinical data from a Phase Ib/II clinical trial (NCT06166836; ...

Oncology Media Relations  [email protected] Investor contact: Lauren Johnson [email protected] ...

A Canadian Cancer Society-funded trial reveals that guided exercise can save and prolong lives by reducing risk of cancer recurrence and second cancers TORONTO , June ...